Evaluation of Primex's PGX Assay to Assess the Clinical Utility of Pharmacogenomics

Status unconfirmed

Conditions studied: Patients on Medications Metabolized Via CYP450

In brief

Primex's PGX assay is an in vitro, semi automated assay, intended for the determination of certain genes involved in drug metabolism utilizing buccal swabs. Detection of certain genotypes is used as an aid in the selection of appropriate medications based on the individuals' specific genotype and should be used in conjunction with other clinical information. The results from this tests constitutes one parameter in a multicriterion medication selection process, encompassing both clinical and laboratory-based assessments.

Key facts

Study ID
NCT02336269
Run by
Primex Clinical Laboratories, Inc.
People needed
100000
Starts
2013-10-01
Expected to finish
2019-10-01
Last updated by the study team
2015-01-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.